Corcept Therapeutics Incorporated
CORT
$71.58
$1.121.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 322.76M | 383.33M | 380.34M | 473.16M | 410.76M |
| Total Receivables | 61.82M | 53.98M | 62.62M | 56.14M | 63.52M |
| Inventory | 14.37M | 12.41M | 8.05M | 8.35M | 7.19M |
| Prepaid Expenses | 8.55M | 9.49M | 15.98M | 5.15M | 21.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 31.00M | 12.39M | -- | 18.06M | -- |
| Total Current Assets | 438.50M | 471.60M | 466.98M | 560.85M | 503.37M |
|
|
|||||
| Total Current Assets | 438.50M | 471.60M | 466.98M | 560.85M | 503.37M |
| Net Property, Plant & Equipment | 7.69M | 8.01M | 8.43M | 7.16M | 188.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 152.22M | 141.11M | 141.54M | 127.24M | 112.10M |
| Total Assets | 846.46M | 840.55M | 784.26M | 714.56M | 655.94M |
|
|
|||||
| Total Accounts Payable | 27.95M | 15.38M | 18.58M | 19.48M | 12.56M |
| Total Accrued Expenses | 110.11M | 122.11M | 99.90M | 75.93M | 70.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 984.00K | 829.00K | 432.00K | 44.00K | 76.00K |
| Total Finance Division Other Current Liabilities | 4.03M | 2.46M | 7.30M | 5.30M | 14.52M |
| Total Other Current Liabilities | 4.03M | 2.46M | 7.30M | 5.30M | 14.52M |
| Total Current Liabilities | 143.07M | 140.77M | 126.22M | 100.75M | 97.20M |
|
|
|||||
| Total Current Liabilities | 143.07M | 140.77M | 126.22M | 100.75M | 97.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.85M | 6.11M | 6.36M | 5.63M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.25M | 14.08M | 12.85M | 11.94M | 10.87M |
| Total Liabilities | 163.17M | 160.96M | 145.42M | 118.31M | 108.07M |
|
|
|||||
| Common Stock & APIC | 863.00M | 832.24M | 806.45M | 781.15M | 758.38M |
| Retained Earnings | 564.28M | 543.74M | 512.99M | 465.78M | 430.29M |
| Treasury Stock & Other | -744.00M | -696.39M | -680.61M | -650.68M | -640.80M |
| Total Common Equity | 683.29M | 679.59M | 638.84M | 596.24M | 547.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 683.29M | 679.59M | 638.84M | 596.24M | 547.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 683.29M | 679.59M | 638.84M | 596.24M | 547.86M |
|
|
|||||